SterileCare Inc

🧪 FAQ: Why do manufacturers of catheter lock solutions mix their solutions? Manufacturers combine products like citrate, heparin, and taurolidine to address the 'Triple Threat'—the challenge of preventing thrombosis, infection, and biofilm formation in catheter management. These combination products tend to be more effective than standalone solutions, as they target multiple issues simultaneously. However, it's important to note that none of these solutions can fully eradicate biofilm, which remains a persistent challenge in vascular access care. Understanding the science behind these formulations is essential for healthcare professionals in optimizing patient care. For more insights on catheter lock solutions, visit sterilecareinc.com. #CatheterCare #InfectionPrevention #HealthcareInnovation #PatientSafety #KiteLock4%

We’re excited to attend the A-Line-ing Best Practices with IPAC and CVAA 2024 Education Symposium in Truro, Nova Scotia on October 24th & 25th! 🎉 This event is a fantastic opportunity to dive into best practices in infection prevention, vascular access, and clinical education, all while networking with fellow professionals in the field. While we’re in Nova Scotia, we’d love to connect! If you’re attending or in the area, let’s schedule a call or meeting to discuss how we can collaborate. 🤝 Reach out to book your time with us! Email info@sterilecareinc.com 📅 #IPAC2024 #CVAA #VascularAccess #NovaScotiaSymposium #HealthcareNetworking

🌟 Exciting News! 🌟 We are proud to be exhibiting at the 36th Annual Conference for the Canadian Association of Nurses in Oncology (CANO/ACIO) in beautiful St. John’s, Newfoundland! This event brings together passionate oncology nursing professionals from across the country, advancing the mission of CANO/ACIO to promote excellence in practice, education, research, and leadership in cancer care. It’s a unique opportunity to connect, learn, and shape the future of oncology nursing. Be sure to visit our booth and tag @CANO/ACIO in your posts to expand your reach! We look forward to seeing you at #CANOACIO2024. If you'd like to schedule a meeting with us in advance of the conference, please email info@sterilecareinc.com Let’s make an impact together! 👩⚕️👨⚕️ #OncologyNursing #CANCare #StJohns2024

🌟 September is National Childhood Cancer Awareness Month 🌟 Every day, brave children and their families face the challenges of childhood cancer. At SterileCare, we are committed to supporting their journey by ensuring safe and effective catheter care. Intraluminal health is a crucial part of treatment for many young patients, and our mission is to help prevent complications and improve their quality of life. This month, let's come together to raise awareness, support ongoing research, and honor the courage of these young warriors. 💛 #ChildhoodCancerAwareness #IntraluminalCare #SterileCare #PediatricHealth #ChildhoodCancer #HealthcareHeroes

🌟 New Research Alert! 🌟 A recent study by Sivaranjani et al. (2024) revealed that all hemodialysis catheters, from patients with or without infections, were found to be colonized by bacteria. Antibiotic resistance and biofilm formation were widespread and not correlated with either catheter group. Colonization happens. Antimicrobial resistance happens. Prevention is paramount. Is your patient protected? Visit sterilecareinc.com or contact us at info@sterilecareinc.com to learn more about a first line of defense catheter lock solution, KiteLock 4%. *Reference: Sivaranjani et al. (2024) | *Studies: Tremain et al. (2024), Hill et al. (2021), Quirt et al. (2021), Liu et al. (2018), Percival et al. (2005), Kite et al. (2004) https://lnkd.in/gx-2U9Et

📅 Join Us at the 46th ESPEN Congress in Milan! We are excited to announce that we will have an exhibit booth at the 46th ESPEN Congress in Milan from September 7-10. 🏛️✨ Learn more about the full agenda and get your tickets to visit us at our booth. If you wish to schedule a meeting with us while we are in Milan, please contact us at info@sterilecareinc.com. Don't miss this opportunity to discover our latest innovations and discuss how KiteLock 4% can enhance catheter care and patient safety. We look forward to seeing you in Milan! #ESPEN2024 #HealthcareInnovation #CatheterCare #KiteLock #MedicalConference #Milan2024

🧐 FAQ: What is Biofilm? 🧐 KiteLock 4% is designed to combat biofilm, ensuring better patient outcomes and device longevity. Learn more about how KiteLock 4% can help maintain catheter health and prevent infections. 📩 For more information or to request our clinical reference guide, email info@sterilecareinc.com. Visit: sterilecareinc.com for further details. #HealthcareInnovation #CatheterCare #KiteLock #PatientSafety #Biofilm #InfectionPrevention

🧬 Understanding T-EDTA’s Mechanism of Action in KiteLock 4% 🧬 KiteLock’s powerful T-EDTA formulation works by targeting calcium (Ca2+) ions, which are critical for the function of blood clotting, microorganisms thriving and the build up of biofilm. By effectively binding to and removing calcium, KiteLock disrupts the formation of clots, kills microorganisms and breaks down biofilm. This not only prevents catheter occlusions but also inhibits the risk of catheter related infections. Want to learn more about how KiteLock 4% can improve catheter care and patient outcomes? Visit: sterilecareinc.com #HealthcareInnovation #CatheterCare #KiteLock #PatientSafety #InfectionPrevention

Contamination happens. Intraluminal care and maintenance requires an effective catheter lock solution that knocks out the triple threat of clots, microorganisms and biofilm. KiteLock is the only lock solution with a mechanism of action that kills microorganisms on contact, stops the coagulation cascade inhibiting clot formation and breaks down the hardy biofilm EPS matrix. To learn more about KiteLock 4% visit sterilecareinc.com #Health #VascularAccess #MedicalDevice

Bacteria shapes every aspect of healthcare. With Kitelock 4%, the impact extends far beyond just preventing bloodstream infections; it creates a ripple effect that transforms the healthcare landscape: 🏥 For Hospitals: - Elevated Patient Outcomes: Implementing Kitelock 4% significantly slashes the incidence of CRBSIs, leading to enhanced patient recovery rates and shorter hospital stays. - Financial Efficiency: Prevention is key. Kitelock 4% not only saves lives but also saves hospitals substantial costs by reducing treatment expenses and complications. - Regulatory Confidence: Kitelock 4% boasts robust antimicrobial properties, ensuring hospitals meet strict infection prevention standards, securing compliance with healthcare quality measures. 👩⚕️ For Patients: - Peace of Mind: Knowing hospitals utilize Kitelock 4% underscores patient safety, fostering a healing environment crucial for recovery. - Pain Reduction: By curbing CRBSI occurrences, Kitelock 4% minimizes patient discomfort linked to invasive catheter procedures, smoothing their healthcare journey. - Swift Recovery: With fewer CRBSI complications, patients enjoy faster recuperation, enabling them to resume their daily lives with minimal interruption. The impact of Kitelock 4% transcends the medical realm, revolutionizing patient care and hospital practices. Join us in shaping a healthier future, one infection at a time. 💪💉 https://lnkd.in/gM-Hq8Hj #HealthcareInnovation #Kitelock4% #InfectionPrevention